RAFAEL
LOPEZ CASTRO
Investigador en el periodo 2023-2023
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institut d'Investigació Biomédica de Bellvitge (2)
2023
-
Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05)
Journal of Clinical Oncology, Vol. 41, Núm. 28, pp. 4478-4485
-
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer
Lung Cancer, Vol. 178, pp. 116-122